{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"primary-cd59-deficiency","columns":[{"gene":"","key":"population-550074cb19dcd0f79a16","label":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","mondoId":"MONDO:0012858","onsetQualifier":null,"originColumnKey":"MONDO:0012858/OMIM:612300","originalViews":[{"key":"MONDO:0012858/OMIM:612300","label":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","scopeLabel":"OMIM:612300","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["19e6ec2d9a5a2b57f90b37ccd68c910eaa75042e9f1df720ec3c17b0649c238f","25f4a39b992891c5a95c03df97c5cac6acda2ce62564a147778749e58cd1782a","5890fa7a963cd1cc5c0a173a1bb7f7dff6db988abc14dafcfbb3894126c2d363","5e0c355d7e943b81e75ae5442f8e9e2756c068b5cbda63f5f27daaba693d2d68","a204112c738c5222743ef26a7cb0c3252e39a59d7a8d8868efb50fdaf6505bb0","ae9086841bfec074a988afd6ec249f30f80ae20ca4edd9586d374eb93152e6e3","bb8da924c179c64c7aca1688f792b8335401d1fb937af67f481bd520ed0b6bfe","c697880d231d19a9a59ede95485bf7649d1c679ff48e5dcbadcdc7a775b551aa","cbd3facb9268bfa083a3fe100391d0774e8d5a5e18543f8d4d90d13dce475a81","ed5f98a9de6ad68b59229844f4fdeea57e24db81f85f3d494b9180a3690083ef"],"recordQualifiers":{},"scopeLabel":"OMIM:612300","sourceIds":["OMIM:612300"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-550074cb19dcd0f79a16"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001284","HP:0001290","HP:0001878","HP:0001252","HP:0002922","HP:0003690","HP:0003470"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":10,"sourceGroups":{"omim":9,"published":1}},"features":[{"hpoId":"HP:0001284","label":"Areflexia","primary":true},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":true},{"hpoId":"HP:0001878","label":"Hemolytic anemia","primary":true},{"hpoId":"HP:0001252","label":"Hypotonia","primary":true},{"hpoId":"HP:0002922","label":"Increased CSF protein concentration","primary":true},{"hpoId":"HP:0003690","label":"Limb muscle weakness","primary":true},{"hpoId":"HP:0003470","label":"Paralysis","primary":true},{"hpoId":"HP:0004818","label":"Paroxysmal nocturnal hemoglobinuria","primary":false},{"hpoId":"HP:0001271","label":"Polyneuropathy","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false}],"ledeHtml":"A rare, genetic, hematologic and neurologic disease characterized by chronic, Coombs-negative hemolysis associated with early-onset, relapsing, immune-mediated, inflammatory, axonal or demyelinating, sensory-motor, peripheral polyneuropathy and isolated or recurrent cerebrovascular events (in anterior or posterior circulation).","mondoId":"MONDO:0012858","node":{"canonicalSlug":"primary-cd59-deficiency","comparisons":[{"documentSha256":"2099f27f2598aa2f762e684082b7fe9bd9719f5d3e8dc9610bc483e2a3d0b9e6","key":"legacy-primary-cd59-deficiency","kind":"legacy","label":"primary CD59 deficiency","memberIds":["MONDO:0012858"],"mondoId":"MONDO:0012858","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/primary-cd59-deficiency.2099f27f2598aa2f762e684082b7fe9bd9719f5d3e8dc9610bc483e2a3d0b9e6.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Primary CD59 deficiency","originalSourceId":"ORPHA:169464","paragraphs":["A rare, genetic, hematologic and neurologic disease characterized by chronic, Coombs-negative hemolysis associated with early-onset, relapsing, immune-mediated, inflammatory, axonal or demyelinating, sensory-motor, peripheral polyneuropathy and isolated or recurrent cerebrovascular events (in anterior or posterior circulation)."],"rawAttribution":"ORPHA:169464","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:01:52Z","upstream":"ORPHA:169464","url":"https://rarediseases.info.nih.gov/diseases/17054"},"ownColumnKeys":["population-550074cb19dcd0f79a16"],"publication":"published","relationships":[{"kind":"parent","label":"familial hemolytic anemia","mondoId":"MONDO:0003689","slug":"familial-hemolytic-anemia"},{"kind":"parent","label":"hereditary peripheral neuropathy","mondoId":"MONDO:0020127","slug":"hereditary-peripheral-neuropathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"19e6ec2d9a5a2b57f90b37ccd68c910eaa75042e9f1df720ec3c17b0649c238f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"25f4a39b992891c5a95c03df97c5cac6acda2ce62564a147778749e58cd1782a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004818","is_excluded":false,"label":"Paroxysmal nocturnal hemoglobinuria","onset_id":null,"reference":"PMID:1699124","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"5890fa7a963cd1cc5c0a173a1bb7f7dff6db988abc14dafcfbb3894126c2d363","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003690","is_excluded":false,"label":"Limb muscle weakness","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5e0c355d7e943b81e75ae5442f8e9e2756c068b5cbda63f5f27daaba693d2d68","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003470","is_excluded":false,"label":"Paralysis","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a204112c738c5222743ef26a7cb0c3252e39a59d7a8d8868efb50fdaf6505bb0","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001878","is_excluded":false,"label":"Hemolytic anemia","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ae9086841bfec074a988afd6ec249f30f80ae20ca4edd9586d374eb93152e6e3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002922","is_excluded":false,"label":"Increased CSF protein concentration","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"bb8da924c179c64c7aca1688f792b8335401d1fb937af67f481bd520ed0b6bfe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001271","is_excluded":false,"label":"Polyneuropathy","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c697880d231d19a9a59ede95485bf7649d1c679ff48e5dcbadcdc7a775b551aa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cbd3facb9268bfa083a3fe100391d0774e8d5a5e18543f8d4d90d13dce475a81","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ed5f98a9de6ad68b59229844f4fdeea57e24db81f85f3d494b9180a3690083ef","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:612300","disease_name":"Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"OMIM:612300","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17054\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:169464</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic, hematologic and neurologic disease characterized by chronic, Coombs-negative hemolysis associated with early-onset, relapsing, immune-mediated, inflammatory, axonal or demyelinating, sensory-motor, peripheral polyneuropathy and isolated or recurrent cerebrovascular events (in anterior or posterior circulation).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17054\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"primary-cd59-deficiency","sourceDocuments":[{"name":"GARD: Primary CD59 deficiency","reviewed":null,"source_release":"2026-10-21T17:01:52Z","url":"https://rarediseases.info.nih.gov/diseases/17054"}],"sourceNote":"","synonyms":["HACD59","hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy","primary CD59 deficiency"],"takeawayHtml":"","title":"primary CD59 deficiency"},"schemaVersion":1}
